Sports Technology Labs Coupon Code: New Discount Expected To Double 2025 Sales

Shelton, CT, Jan. 22, 2025 (GLOBE NEWSWIRE) — Sports Technology Labs, a leading innovator in research chemicals like peptides and SARMS, is excited to announce a limited-time promotion that will give customers 10% off their next purchase. To take advantage of the Sports Technology Labs coupon code, customers can simply place an order on the […]

NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025

(NASDAQ:NXGL),(NASDAQ:NXGLW), Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth year-over-year of over 100% for the third consecutive year Management expects to generate at least $13 million in revenue for 2025 and to achieve positive cash flow from operations during the year LANGHORNE, Pa.,

Chemyo Discount Code Released: New Coupon Expected To Double 2025 Sales

Wilmington, DE, Jan. 22, 2025 (GLOBE NEWSWIRE) — Chemyo, a leader in premium chemical products, is thrilled to announce the launch of an exclusive 10% discount offer for customers. Effective immediately, customers can use the Chemyo discount code REDEEM10 at checkout to enjoy significant savings on their next order. As a company committed to providing

Free Gold IRA Kit for 2025 Now Available for Download

Dallas, TX, Jan. 22, 2025 (GLOBE NEWSWIRE) — Gold Investment Planner, a reliable source for advice on self-directed IRAs and precious metals providers, offers a complimentary gold kit and addresses common questions about investing in gold. With gold prices on the rise due to market fluctuations and economic instability, a free gold IRA kit has

Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies

(OTCQB:CYTOF),(OTC US:CYTOF), Hamilton, Bermuda, Jan. 22, 2025 (GLOBE NEWSWIRE) — Exploring use of Altamira's RNA nanoparticles in conjunction with radiopharmaceutical cancer treatment Project collaboration partner will have option to negotiate licensing and supply agreement Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (OTCQB:CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets beyond

The Best Cars on Sale in 2025: Edmunds Top Rated Awards Revealed

SANTA MONICA, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) — The car shopping experts at Edmunds today announced the winners of the Edmunds Top Rated Awards 2025, recognizing the best vehicles on sale today. Reflecting current market trends for value and efficiency, five of our six winners are electrified, including the Edmunds Top Rated 2025 Best

Reading International reports strong 2024 Holiday Box Office Results

(NASDAQ:RDI), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Reading International, Inc. (NASDAQ: RDI) (“Reading” or our “Company”), an internationally diversified cinema and real estate company with operations and assets in the United States, Australia, and New Zealand, today announced that its global cinema operations achieved several box office records over the November and December

LeadCoverage Opens London UK Office, Expanding Global Supply Chain Go To Market Consulting Practice

ATLANTA, Jan. 22, 2025 (GLOBE NEWSWIRE) — LeadCoverage, the premier supply chain go-to-market (GTM) consulting group, announces its expansion into Europe with the opening of a new office in London, United Kingdom. This milestone marks another step in LeadCoverage's global growth, establishing a presence to continue serving the supply chain industry throughout Europe, the Middle

NeuroSigma Announces Patent Application Protecting Use of Trigeminal Nerve Stimulation to Include Treatment of Dyslexia and Other Neurodevelopmental Disorders

LOS ANGELES, Jan. 22, 2025 (GLOBE NEWSWIRE) — NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing the Monarch external Trigeminal Nerve Stimulation (eTNS) device for treating ADHD, today announced the filing of a new patent related to use of eTNS for treating neurodevelopmental disorders. The patent filing, Trigeminal Nerve Stimulation as Treatment for Neurodevelopmental Disorders

KRTL Holding Group Inc. Announces Milestone Achievement: FDA Registration of Industria Quimico Farmaceutica SIGMA CORP. S.R.L.’s Federal Establishment Identifier

(Other OTC:KRTL),(OTC US:KRTL), Lakewood, CO, Jan. 22, 2025 (GLOBE NEWSWIRE) — KRTL Holding Group Inc. proudly announces the successful registration of Industria Quimico Farmaceutica SIGMA CORP. S.R.L. (SIGMA), a premier Bolivian pharmaceutical company, with the United States Food and Drug Administration's (FDA) Federal Establishment Identifier (FEI). This pivotal milestone highlights the collaboration between KRTL and

Scroll to Top